Search

Your search keyword '"Chinnaiyan, Arul M"' showing total 2,760 results

Search Constraints

Start Over You searched for: Author "Chinnaiyan, Arul M" Remove constraint Author: "Chinnaiyan, Arul M"
2,760 results on '"Chinnaiyan, Arul M"'

Search Results

1. A Systematic Overview of Single-Cell Transcriptomics Databases, their Use cases, and Limitations

3. NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

6. Reply to “Contextualizing racial associations in prostate cancer to expose structural causes”

7. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

8. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

9. Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

10. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

14. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13

15. Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition

18. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

19. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

22. Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

24. Comprehensive proteogenomic characterization of rare kidney tumors

25. Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

27. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

28. Pan-cancer proteogenomics characterization of tumor immunity

29. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT

30. Deep learning integrates histopathology and proteogenomics at a pan-cancer level

31. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

33. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

34. Pan-cancer proteogenomics connects oncogenic drivers to functional states

35. Proteogenomic data and resources for pan-cancer analysis

37. The DNA methylation landscape of advanced prostate cancer

38. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer

40. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19

41. Abstract PR010: CDK12 loss promotes prostate cancer development while exposing vulnerabilities to paralog-based synthetic lethality

42. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway

43. Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

44. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response

45. Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer

48. The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma

49. CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue

Catalog

Books, media, physical & digital resources